Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 16:13:953188.
doi: 10.3389/fneur.2022.953188. eCollection 2022.

Optical coherence tomography assessment of axonal and neuronal damage of the retina in patients with familial and sporadic multiple sclerosis

Affiliations

Optical coherence tomography assessment of axonal and neuronal damage of the retina in patients with familial and sporadic multiple sclerosis

Monika Grudziecka Pyrek et al. Front Neurol. .

Abstract

Objective: To assess axonal and neuronal damage of the retina in patients with familial (fMS) and sporadic multiple sclerosis (sMS).

Methods: 87 relapsing-remitting MS patients (45 patients with sMS, 42 patients with fMS) and 30 healthy controls were included in the study. Optical coherence tomography (OCT) was performed with the spectral domain optical coherence tomography (SD-OCT, Heidelberg Engineering, Germany). The peripapillary retinal nerve fiber layer (pRNFL) thickness, ganglion cell-inner plexiform layer (GCIPL) thickness, total macular volume (TMV) and the inner nuclear layer (INL) thickness were measured.

Results: A significant reduction of the pRNFL thickness was detected in sMS and fMS compared to the control group (86.29 (+/- 16.13) μm in sMS, 84.78 (+/- 12.92) μm in fMS, 98.93 (+/- 6.71) μm in control group; p < 0.001). There was no significant difference in the pRNFL thickness between sMS and fMS (p = 0.5239). The GCIPL thickness was significantly decreased in sMS and fMS compared to the control group [66.0581 (+/- 11.2674) μm in sMS, 63.8386 (+/-10.004) μm in fMS, 76.5074 (+/- 5.0004) μm in control group; p < 0.001]. A significant reduction of the TMV was shown in sMS and fMS compared to the control group [8.4541(+/- 0.4727) mm3 in sMS, 8.3612 (+/- 0.4448) mm3 in fMS, 8.8387 (+/- 0.314) mm3 in control group; p < 0.0011]. No difference in the GCIPL thickness and TMV between sMS and fMS was found (p = 0.3689 and p = 0.3758, respectively). The INL thickness in sMS and fMS did not differ compared to the control group [34.2323 (+/- 2.7006) μm in sMS, 34.5159 (+/- 2.9780) μm in fMS, 33.6148 (+/- 2.0811) μm in control group; p = 0.5971 and p = 0.1870, respectively] and between the two forms (p = 0.4894).

Conclusion: We confirmed the presence of axonal and neuronal damage of the retina in sMS and fMS. Both forms of MS did not differ significantly from each other with respect to RFNL, GCIPL, MV and INL. ON induced significant reduction of the pRNFL, GCIPL and MV in both groups of pwMS.

Keywords: familial multiple sclerosis; ganglion cell and inner plexiform layer; inner nuclear layer; macular volume; optical coherence tomogaphy; retinal nerve fiber layer; sporadic multiple sclerosis.

PubMed Disclaimer

Conflict of interest statement

MG has received a grant from the National Science Center. KS has received personal compensation for consulting from Biogen, Celgene, GeNeuro, Merck, Novartis, Polpharma, Sanofi, Roche, TG Therapeutics, and received research support from Merck and Roche.

Figures

Figure 1
Figure 1
Comparison of the pRNFL thickness in Non-ON eyes between sMS and fMS.
Figure 2
Figure 2
Comparison of the pRNFL thickness in ON eyes between sMS and fMS.
Figure 3
Figure 3
Comparison of the GCIPL thickness in Non-ON eyes between sMS and fMS.
Figure 4
Figure 4
Comparison of the GCIPL thickness in ON eyes between sMS and fMS.

References

    1. Hartung HP, Will RG, Francis D, Grosse-Wilde H, Rudge P, Scaravilli F et al. Familial multiple sclerosis. J Neurol Sci. (1988) 83:259–68. 10.1016/0022-510X(88)90073-1 - DOI - PubMed
    1. Sadovnick AD, Baird PA. The familial nature of multiple sclerosis: age-corrected empiric recurrence risks for children and siblings of patients. Neurology. (1988) 38:990–1. 10.1212/WNL.38.6.990 - DOI - PubMed
    1. Ebers GC, Koopman WJ, Hader W, Sadovnick AD, Kremenchutzky M, Mandalfino P et al. The natural history of multiple sclerosis: a geographically based study: 8: familial multiple sclerosis. Brain. (2000) 123:641–9. 10.1093/brain/123.3.641 - DOI - PubMed
    1. Harirchian MH, Fatehi F, Sarraf P, Honarvar NM, Bitarafan S. Worldwide prevalence of familial multiple sclerosis: a systematic review and meta-analysis. Mult Scler Relat Disord. (2018) 20:43–7. 10.1016/j.msard.2017.12.015 - DOI - PubMed
    1. Sawcer S. The complex genetics of multiple sclerosis: pitfalls and prospects. Brain. (2008) 131:3118–31. 10.1093/brain/awn081 - DOI - PMC - PubMed

LinkOut - more resources